Oxidative stress is implicated in the pathogenesis of neurodegenerative diseases, including sporadic Alzheimer’s disease (AD). Mitochondrial DNA (mtDNA) deletions are markers of oxidative damage with an age-dependent accumulation. In a previous study, we analyzed mtDNA levels in diverse neuronal cell types in order to unravel the impact of oxidative stress in brains of AD patients. The aim of this study was to identify possible correlations between mtDNA deletion levels of selected astrocytes and microglia from three brain regions with different vulnerability to AD pathology and different stages of disease compared to controls. Our results reflect a higher vulnerability of hippocampal astrocytes and microglia to oxidative stress compared to other brain regions, such as cerebellum and brainstem.
LarnerAJ (1997) The cerebellum in Alzheimer’s disease. Dement Geriatr Cogn Disord8, 203–209.
3.
MavroudisIA, FotiouDF, AdipepeLF, MananiMG, NjauSD, PsaroulisD, CostaVG, BaloyannisSJ (2010) Morphological changes of the human purkinje cells and deposition of neuritic plaques and neurofibrillary tangles on the cerebellar cortex of Alzheimer’s disease. Am J Alzheimers Dis Other Demen25, 585–591.
4.
GrinbergLT, RubU, FerrettiRE, NitriniR, FarfelJM, PolichisoL, GiergaK, Jacob-FilhoW, HeinsenH (2009) The dorsal raphe nucleus shows phospho-tau neurofibrillary changes before the transentorhinal region in Alzheimer’s disease. A precocious onset? Neuropathol Appl Neurobiol35, 406–416.
5.
SimicG, StanicG, MladinovM, Jovanov-MilosevicN, Kos-tovicI, HofPR (2009) Does Alzheimer’s disease begin in the brainstem?Neuropathol Appl Neurobiol35, 532–554.
6.
BraakH, Del TrediciK (2011) The pathological process underlying Alzheimer’s disease in individuals under thirty. Acta Neuropathol121, 171–181.
7.
FallgatterAJ, NeuhauserB, HerrmannMJ, EhlisAC, WagenerA, ScheuerpflugP, ReinersK, RiedererP (2003) Far field potentials from the brain stem after transcutaneous vagus nerve stimulation. J Neural Transm110, 1437–1443.
8.
NomuraS, MizunoN (1983) Central distribution of efferent and afferent components of the cervical branches of the vagus nerve. A HRP study in the cat. Anat Embryol (Berl)166, 1–18.
9.
PolakT, EhlisAC, LangerJB, PlichtaMM, MetzgerF, RingelTM, FallgatterAJ (2007) Non-invasive measurement of vagus activity in the brainstem - a methodological progress towards earlier diagnosis of dementias?J Neural Transm114, 613–619.
10.
BraakH, Del TrediciK (2011) Alzheimer’s pathogenesis: Is there neuron-to-neuron propagation?Acta Neuropathol121, 589–595.
11.
BerridgeMJ (2010) Calcium hypothesis of Alzheimer’s disease. Pflugers Arch459, 441–449.
12.
MudherA, ColinM, DujardinS, MedinaM, DewachterI, NainiSMA, MandelkowEM, MandelkowE, BueeL, GoedertM, BrionJP (2017) What is the evidence that tau pathology spreads through prion-like propagation?Acta Neuropathol Commun5, 99.
13.
ShigenagaMK, HagenTM, AmesBN (1994) Oxidative damage and mitochondrial decay in aging. Proc Natl Acad SciUSA91, 10771–10778.
MajdS, PowerJHT (2018) Oxidative stress and decreased mitochondrial superoxide dismutase 2 and peroxiredoxin 1 and 4 based mechanism of concurrent activation of AMPK and mTOR in Alzheimer’s disease. Curr Alzheimer Res8, 764–776.
MeissnerC, BruseP, MohamedSA, SchulzA, WarnkH, StormT, OehmichenM (2008) The 4977 bp deletion of mitochondrial DNA in human skeletal muscle, heart and different areas of the brain: A useful biomarker or more?Exp Gerontol43, 645–652.
18.
MeissnerC, BruseP, OehmichenM (2006) Tissue-specific deletion patterns of the mitochondrial genome with advancing age. Exp Gerontol41, 518–524.
19.
LinMT, BealMF (2006) Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature443, 787–795.
20.
Corral-DebrinskiM, HortonT, LottMT, ShoffnerJM, McKeeAC, BealMF, GrahamBH, WallaceDC (1994) Marked changes in mitochondrial DNA deletion levels in Alzheimer brains. Genomics23, 471–476.
21.
BlanchardBJ, ParkT, FrippWJ, LermanLS, IngramVM (1993) A mitochondrial DNA deletion in normally aging and in Alzheimer brain tissue. Neuroreport4, 799–802.
VasileF, DossiE, RouachN (2017) Human astrocytes: Structure and functions in the healthy brain. Brain Struct Funct222, 2017–2029.
24.
SouthamKA, VincentAJ, SmallDH (2016) Do microglia default on network maintenance in Alzheimer’s disease?J Alzheimers Dis51, 657–669.
25.
KatsumotoA, LuH, MirandaAS, RansohoffRM (2014) Ontogeny and functions of central nervous system macrophages. J Immunol193, 2615–2621.
26.
StreitWJ, BraakH, XueQS, BechmannI (2009) Dystrophic (senescent) rather than activated microglial cells are associated with tau pathology and likely precede neurodegeneration in Alzheimer’s disease. Acta Neuropathol118, 475–485.
27.
GutierrezA, VitoricaJ (2018) Toward a new concept of Alzheimer’s disease models: A perspective from neuroinflammation. J Alzheimers Dis64, 329–338.
28.
BenderA, SchwarzkopfRM, McMillanA, KrishnanKJ, RiederG, NeumannM, ElstnerM, TurnbullDM, Klop-stockT (2008) Dopaminergic midbrain neurons are the prime target for mitochondrial DNA deletions. J Neurol255, 1231–1235.
29.
BenderA, KrishnanKJ, MorrisCM, TaylorGA, ReeveAK, PerryRH, JarosE, HershesonJS, BettsJ, KlopstockT, TaylorRW, TurnbullDM (2006) High levels of mitochondrial DNA deletions in substantia nigra neurons in aging and Parkinson disease. Nat Genet38, 515–517.
30.
ElstnerM, MullerSK, LeidoltL, LaubC, KriegL, Schlau-draffF, LissB, MorrisC, TurnbullDM, MasliahE, ProkischH, KlopstockT, BenderA (2011) Neuromelanin, neuro-transmitter status and brainstem location determine the differential vulnerability of catecholaminergic neurons to mitochondrial DNA deletions. Mol Brain4, 43.
31.
KrishnanKJ, BenderA, TaylorRW, TurnbullDM (2007) A multiplex real-time PCR method to detect and quantify mitochondrial DNA deletions in individual cells. Anal Biochem370, 127–129.
32.
RuijterJM, RamakersC, HoogaarsWM, KarlenY, BakkerO, van den HoffMJ, MoormanAF (2009) Amplification efficiency: Linking baseline and bias in the analysis of quantitative PCR data. Nucleic Acids Res37, e45.
33.
PfafflMW (2001) A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res29, e45.
34.
FilousAR, SilverJ (2016) Targeting astrocytes in CNS injury and disease: A translational research approach. Prog Neurobiol144, 173–187.
35.
AbramovAY, CanevariL, DuchenMR (2004) Beta-amyloid peptides induce mitochondrial dysfunction and oxidative stress in astrocytes and death of neurons through activation of NADPH oxidase. J Neurosci24, 565–575.
36.
RodriguezJJ, OlabarriaM, ChvatalA, VerkhratskyA (2009) Astroglia in dementia and Alzheimer’s disease. Cell Death Differ16, 378–385.
37.
SjobeckM, EnglundE (2001) Alzheimer’s disease and the cerebellum: A morphologic study on neuronal and glial changes. Dement Geriatr Cogn Disord12, 211–218.
38.
DaviesDS, MaJ, JegatheesT, GoldsburyC (2017) Microglia show altered morphology and reduced arborization in human brain during aging and Alzheimer’s disease. Brain Pathol27, 795–808.
